Insplorion AB (INSP) - Total Liabilities

Latest as of September 2025: Skr3.60 Million SEK ≈ $387.74K USD

Based on the latest financial reports, Insplorion AB (INSP) has total liabilities worth Skr3.60 Million SEK (≈ $387.74K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Insplorion AB - Total Liabilities Trend (2012–2024)

This chart illustrates how Insplorion AB's total liabilities have evolved over time, based on quarterly financial data. See Insplorion AB (INSP) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Insplorion AB Competitors by Total Liabilities

The table below lists competitors of Insplorion AB ranked by their total liabilities.

Company Country Total Liabilities
Savoreat Ltd
TA:SVRT
Israel ILA840.00
Distribution Finance Capital Holdings PLC
LSE:DFCH
UK GBX872.21 Million
Im Cannabis Corp
NASDAQ:IMCC
USA $35.35 Million
US Financial 15 Split Corp
TO:FTU
Canada CA$12.91 Million
Golden Prospect Precious Metals Ltd
LSE:GPM
UK GBX3.68 Million
Mulberry Group PLC
LSE:MUL
UK GBX100.94 Million
Speedy Hire PLC
LSE:SDY
UK GBX385.50 Million
Altai Resources Inc.
V:ATI
Canada CA$25.52K

Liability Composition Analysis (2012–2024)

This chart breaks down Insplorion AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Insplorion AB worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.76 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.15 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.13 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Insplorion AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Insplorion AB (2012–2024)

The table below shows the annual total liabilities of Insplorion AB from 2012 to 2024.

Year Total Liabilities Change
2024-12-31 Skr5.29 Million
≈ $569.29K
-0.41%
2023-12-31 Skr5.31 Million
≈ $571.66K
-31.14%
2022-12-31 Skr7.71 Million
≈ $830.15K
-32.82%
2021-12-31 Skr11.48 Million
≈ $1.24 Million
-32.45%
2020-12-31 Skr17.00 Million
≈ $1.83 Million
+73.76%
2019-12-31 Skr9.78 Million
≈ $1.05 Million
+5.26%
2018-12-31 Skr9.29 Million
≈ $1.00 Million
+38.55%
2017-12-31 Skr6.71 Million
≈ $721.89K
+7.76%
2016-12-31 Skr6.22 Million
≈ $669.91K
+3.20%
2015-12-31 Skr6.03 Million
≈ $649.14K
+0.30%
2014-12-31 Skr6.01 Million
≈ $647.20K
+20.56%
2013-12-31 Skr4.99 Million
≈ $536.84K
+1920.54%
2012-12-31 Skr246.89K
≈ $26.57K
--

About Insplorion AB

ST:INSP Sweden Scientific & Technical Instruments
Market Cap
$1.12 Million
Skr10.44 Million SEK
Market Cap Rank
#30440 Global
#717 in Sweden
Share Price
Skr0.13
Change (1 day)
-6.36%
52-Week Range
Skr0.04 - Skr0.42
All Time High
Skr73.98
About

Insplorion AB (publ) provides hydrogen sensors and scientific instruments for biomolecular and battery research primarily in Sweden. The company offers Insplorion Acoulyte, a combined optical spectroscopy with Quartz crystal microbalance with dissipation monitoring; Insplorion XNano that enables realtime refractive index change measurements in both gas- and liquid flow measurements; and Insplorio… Read more